SynthesisBMC infectious diseases2024
Prevalence, risk factors, and antimicrobial resistance of endemic healthcare-associated infections in Africa: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- Ciprofloxacin resistance in community and hospital-acquired urinary tract infections: a systematic review and meta-analysis from African population.BMC infectious diseases · 2025Pooled it
- Prevalence of phenotypic drug resistance profiles and multi-drug-resistant Pseudomonas and Acinetobacter species recovered from clinical specimens in Ethiopia: a systematic review and meta-analysis.BMC infectious diseases · 2025Pooled it
- Prevalence and determinants of microbiologically unconfirmed healthcare-associated infections among hospitalized patients in Western Sierra Leone, 2024: a point prevalence survey.Infection prevention in practice · 2026Article
- Appraising the infection prevention and control practices at two referral hospitals in Malawi: a mixed methods situational analysis.Antimicrobial resistance and infection control · 2026Article
- Assessment of infection prevention and control practices in healthcare facilities in the O.R. Tambo district municipality using the WHO infection prevention and control assessment framework.Frontiers in public health · 2026Article
- Transmission dynamics of Klebsiella pneumoniae in a neonatal intensive care unit in Zambia before and after an infection control bundle.PLOS global public health · 2026Article
- Article
- Trends and risk factors of multidrug-resistant hospital-acquired infections in a Tunisian university hospital: repeated point prevalence surveys, 2023-2025.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Antimicrobial resistance of Enterobacterales in Central Africa: a systematic review and meta-analysis.Communications medicine · 2025Article
- Surveillance on antimicrobial resistance: bacteriological monitoring and resistance profiles of isolates from surfaces and equipment at a Ghanaian tertiary healthcare facility.BMC infectious diseases · 2025Article
- National Update on Healthcare-Associated Infections in Iran for 2023-Based on the Iranian Nosocomial Infections Surveillance (INIS) System.Journal of epidemiology and global health · 2025Article
- Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance.npj antimicrobials and resistance · 2025Review
- Healthcare-Associated Infections: The Role of Microbial and Environmental Factors in Infection Control-A Narrative Review.Infectious diseases and therapy · 2025Review
- Compliance with transmission-based precautions, and associated factors among healthcare providers in Cameroon: a cross-sectional study.Antimicrobial resistance and infection control · 2025Article
- Antimicrobial Resistance Surveillance of Skin and Soft Tissue Infections: Hospital-Wide Bacterial Species and Antibiograms to Inform Management at a Zonal Tertiary Hospital in Mwanza, Tanzania.Infection and drug resistance · 2025Article
- Evaluating infection prevention and control programs in Zambian hospitals using the WHO infection prevention and control assessment framework tool.Frontiers in public health · 2025Article
- Impact of Clinical Factors on Nosocomial Infections and Bacterial Resistance in Resuscitation Settings in Abidjan, Côte d'Ivoire: Retrospective Cross-Sectional Study.Infection and drug resistance · 2025Article
- Designing implementation strategies for improving infection prevention and control in acute healthcare facilities in Malawi: A formative study protocol.Wellcome open research · 2025Article
- Article
- Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundHealthcare-associated infections (HCAI) place a significant burden on healthcare systems globally. This systematic review and meta-analysis aimed to investigate the prevalence, risk factors, and aetiologic agents of endemic HCAI in Africa.
methodsMEDLINE/PubMed, CINAHL, and Global Health databases (EBSCOhost interface) were searched for studies published in English and French describing HCAI in Africa from 2010 to 2022. We extracted data on prevalence of HCAI, risk factors, aetiologic agents, and associated antimicrobial resistance patterns. We used random-effects models to estimate parameter values with 95% confidence intervals for risk factors associated with HCAI. This study was registered in PROSPERO (CRD42022374559) and followed PRISMA 2020 guidelines.
resultsOf 2541 records screened, 92 were included, comprising data from 81,968 patients. Prevalence of HCAI varied between 1.6 and 90.2% with a median of 15% across studies. Heterogeneity (I
conclusionsHCAI is a greater problem in Africa than other regions, however, there remains a paucity of data to guide local action. There is a clear need to develop and validate sustainable HCAI definitions in Africa to support the implementation of routine HCAI surveillance and inform implementation of context appropriate infection prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.